Merit Medical Systems Inc（MMSI）财务数据MMSIMerit Medical Systems Inc

Merit Medical Systems Inc (MMSI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Foundational Access, accounting for 138.6% of total sales, equivalent to $580.63M. Other significant revenue streams include Foundational OEM and Foundational Vascular Intervention. Understanding this composition is critical for investors evaluating how MMSI navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Merit Medical Systems Inc maintains a gross margin of 51.37%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 16.28%, while the net margin is 9.26%. These profitability ratios, combined with a Return on Equity (ROE) of 9.19%, provide a clear picture of how effectively MMSI converts its operational activities into shareholder value.

In the context of the broader market, MMSI competes directly with industry leaders such as SHC and MMED. With a market capitalization of $5.42B, it holds a significant position in the sector. When comparing efficiency, MMSI's gross margin of 51.37% stands against SHC's 54.44% and MMED's 57.35%. Such benchmarking helps identify whether Merit Medical Systems Inc is trading at a premium or discount relative to its financial performance.

Merit Medical's financial performance shows consistent revenue growth, with Q2 2026 revenue at $418.8 million, up from $382.5 million in Q1 2026. The gross margin has improved to 51.37% in Q2 2026, reflecting strong profitability.